≡ Risteys
R13

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

Sequelae of injuries involving multiple and unspecified body regions

Endpoint Browser

ST19_SEQUEL_INJURI_INVOLVI_MULTIPLE_UNSPE_BODY_REGIONS

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519972

1. Apply sex-specific rule

None

519972

2. Check conditions

None

519972

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — T94
  • Cause of death: ICD-10 — T94

2 out of 7 registries used, show all original rules.

89

4. Check minimum number of events

None

89

5. Include endpoints

None

89

6. Filter based on genotype QC (FinnGen only)

83

Control definitions (FinnGen only)

Control exclude
ST19_SEQUEL_INJURI_POISO_OTHER_CONSE_EXTER_CAUSES

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
T9
Name in latin
Sequelae laesionum regionum corporis multarum sive non specificatarum

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 83 31 52
Unadjusted period prevalence (%) 0.02 0.01 0.02
Median age at first event (years) 66.36 53.18 74.21

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
89
Matched controls
890
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
T94.0
ICD-10 Finland
Sequelae of injuries involving multiple body regions
+∞
90.8
71
*
T94.1
ICD-10 Finland
Sequelae of injuries, not specified by body region
+∞
19.5
18
*
Y89.1
ICD-10 Finland
Sequelae of war operations
119.2
18.3
19
*
X59
ICD-10 Finland
Exposure to unspecified factor
6.9
16.3
33
70
N03AX16
ATC
[U] pregabalin
6.4
15.4
34
78
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
6.5
14.0
29
62
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
6.6
11.8
22
42
N03AX12
ATC
[U] gabapentin; oral
5.6
10.9
25
58
T90.5
ICD-10 Finland
Sequelae of intracranial injury
+∞
10.6
10
*
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
12.9
10.4
18
17
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
19.7
10.3
15
9
N02AX02
ATC
tramadol; systemic, rectal
4.0
9.7
50
215
V49.9
ICD-10 Finland
Car occupant [any] injured in unspecified traffic accident
16.1
9.6
15
11
NE1AA
NOMESCO Finland
Pelvis X-ray examination
9.0
7.8
16
21
TNX32
NOMESCO Finland
Custom moulded splint, unspecified region
15.2
7.6
12
9
N03AE01
ATC
clonazepam; systemic
9.2
7.5
15
19
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
22.2
7.3
10
5
ZXE10
NOMESCO Finland
More than one and less than three hours
3.4
7.2
41
180
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
3.4
7.1
38
161
ZXD05
NOMESCO Finland
Urgent procedure
3.4
6.8
34
137
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
24.7
6.8
9
*
S32.7
ICD-10 Finland
Multiple fractures of lumbar spine and pelvis
75.0
6.5
7
*
X58
ICD-10 Finland
Exposure to other specified factors
4.3
6.4
19
53
S06.0
ICD-10 Finland
Concussion
4.8
6.4
16
39
NFC20
NOMESCO Finland
Secondary implantation of hip prosthesis
28.9
6.3
8
*
E9999
ICD-8 Finland
Late effect of injury due to war operations
28.9
6.3
8
*
M16.5
ICD-10 Finland
Other post-traumatic coxarthrosis
+∞
6.3
6
*
NFH30
NOMESCO Finland
Reduction of dislocation prosthesis of hip joint, closed
+∞
6.3
6
*
ABD30
NOMESCO Finland
Implantation of spinal stimulation device
+∞
6.3
6
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.9
6.2
21
65

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
21
65
3.92
6.20
3.0
1.7
—
—
—
0
0
26
120
2.65
3.87
5.5
4.0
—
—
—
0
0
17
66
2.95
3.45
2.6
1.3
—
—
—
0
0
30
162
2.28
3.13
3.8
2.1
691.37
176.54
u/l
0.79
30
149
8
17
5.06
2.99
3.6
2.5
—
—
—
0
0
9
24
4.05
2.76
14.7
5.0
—
—
—
0
0
28
155
2.18
2.71
3.6
2.3
55.75
55.72
u/l
0.00
28
145
7
16
4.65
2.53
4.0
2.9
25.36
24.61
mmol/l
—
7
16
16
74
2.42
2.31
1.9
2.0
2.39
2.38
g/l
0.01
16
65
12
51
2.56
2.05
1.5
1.6
—
—
—
0
0
7
21
3.53
2.01
1.0
1.1
—
—
—
0
0
35
231
1.85
2.00
11.2
13.6
1.21
1.27
inr
—
10
76
15
73
2.27
1.94
1.7
2.0
17.79
25.36
%
—
10
58
16
81
2.19
1.89
1.9
2.0
7.91
15.00
umol/l
4.66
16
74
47
345
1.77
1.86
5.2
3.8
—
18.57
—
0
7
8
29
2.93
1.84
6.0
7.9
95.09
94.65
%
—
8
29
24
146
1.88
1.74
3.4
2.1
—
—
—
0
0
34
232
1.75
1.70
3.6
5.7
—
—
—
0
0
8
32
2.64
1.64
2.3
4.7
—
—
—
0
0
27
180
1.72
1.44
1.7
1.7
77.22
98.88
pmol/l
1.56
12
88
13
218
0.53
1.30
2.0
2.8
—
—
—
0
0
22
143
1.72
1.27
5.7
2.6
—
—
—
0
0
44
344
1.55
1.21
4.3
3.7
—
—
—
0
0
7
31
2.36
1.13
6.3
7.3
0.53
0.69
%
—
7
31
7
31
2.36
1.13
6.3
7.3
1.34
1.63
%
—
7
31
40
310
1.53
1.13
7.9
4.2
6.80
6.80
mmol/l
0.00
40
280
22
148
1.65
1.12
4.5
3.4
0.00
0.00
estimate
—
8
46
34
256
1.53
1.08
3.2
5.5
0.20
0.18
e9/l
0.29
27
234
27
194
1.56
1.05
1.7
1.9
—
—
—
0
0
47
382
1.49
1.03
3.7
3.8
14.86
14.80
pmol/l
0.05
39
341
7
35
2.08
1.02
16.9
2.8
—
—
—
0
0
7
37
1.97
0.96
1.3
1.2
—
—
—
0
0
6
27
2.31
0.95
5.7
4.0
24.30
24.83
mmol/l
—
6
27
6
29
2.14
0.91
3.2
3.1
0.12
0.09
e6/l
—
6
29
33
255
1.47
0.91
4.0
3.5
0.00
0.00
estimate
—
8
49
8
43
1.94
0.90
5.1
5.4
—
—
—
0
0
10
58
1.82
0.83
8.6
7.2
103.10
103.52
mmol/l
—
10
58
5
23
2.24
0.77
1.0
4.7
—
—
—
0
0
31
244
1.42
0.76
3.5
5.5
0.04
0.04
e9/l
0.38
23
220
5
24
2.15
0.76
2.2
1.4
—
—
—
0
0
37
301
1.39
0.75
8.8
10.4
4.52
4.30
e9/l
0.17
32
259
5
25
2.06
0.74
6.6
4.4
—
—
—
0
0
5
25
2.06
0.74
2.2
1.3
—
—
—
0
0
62
552
1.41
0.72
26.0
14.2
4.04
3.97
mmol/l
1.24
62
527
5
26
1.98
0.72
2.2
1.3
—
—
—
0
0
5
26
1.98
0.72
2.2
1.3
—
—
—
0
0
17
120
1.52
0.71
3.8
3.2
—
—
—
0
0
7
42
1.72
0.70
1.6
2.0
409.14
398.97
nmol/l
—
7
37
19
138
1.48
0.70
3.1
2.6
—
—
—
0
0
32
257
1.38
0.69
5.0
4.8
0.00
0.00
estimate
—
8
46
26
202
1.41
0.68
3.9
3.9
13.15
40.19
ng/l
1.72
21
132
32
260
1.36
0.64
4.1
3.5
0.00
0.00
estimate
—
8
42
61
547
1.37
0.64
26.5
14.2
139.25
139.73
mmol/l
0.74
61
524
30
243
1.35
0.61
3.4
5.4
0.66
0.58
e9/l
0.60
23
220
20
151
1.42
0.61
3.6
2.8
19.09
75.40
e6/l
1.38
15
119
0
21
0.00
0.61
0.0
1.1
—
—
—
0
0
60
542
1.33
0.56
21.1
12.5
29.00
23.13
mg/l
0.52
55
414
9
64
1.45
0.53
2.6
2.4
11.56
7.44
umol/l
—
9
54
7
48
1.50
0.48
1.4
1.3
—
—
—
0
0
7
49
1.46
0.47
2.6
3.2
—
—
—
0
0
30
252
1.29
0.46
3.6
5.4
1.83
1.80
e9/l
0.05
24
233
62
571
1.28
0.45
23.5
14.6
76.15
78.77
umol/l
0.39
62
571
8
57
1.44
0.43
2.3
5.0
1.06
1.09
mmol/l
—
8
50
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
18
0.00
0.40
0.0
1.4
—
192.38
—
0
8
6
83
0.70
0.25
1.3
1.6
—
—
—
0
0
44
474
0.86
0.25
28.4
15.6
15.45
14.71
%
0.27
44
463
51
543
0.86
0.24
4.1
4.8
2.77
2.74
mmol/l
0.09
43
495
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
22.31
—
0
10
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
3.0
—
0.11
—
0
7
0
13
0.00
0.21
0.0
2.0
—
3.14
—
0
5
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
7
59
1.20
0.18
1.3
1.2
—
—
—
0
0
51
485
1.12
0.16
4.4
4.3
1.84
1.94
mu/l
0.21
45
434
10
118
0.83
0.15
1.5
1.3
0.32
1.83
u/ml
—
5
32
51
533
0.90
0.14
3.9
4.3
1.44
1.46
mmol/l
0.11
42
486
51
532
0.90
0.13
3.7
4.3
4.62
4.65
mmol/l
0.06
43
491
15
134
1.14
0.11
2.3
3.8
—
—
—
0
0
62
601
1.10
0.11
30.6
19.0
257.03
248.05
e9/l
0.34
62
585
62
601
1.10
0.11
30.4
19.0
91.05
91.15
fl
0.06
62
588
14
156
0.88
0.11
1.4
1.4
—
—
—
0
0
62
602
1.10
0.10
30.4
18.9
30.22
30.37
pg
0.33
62
589
62
602
1.10
0.10
30.7
19.1
131.11
136.55
g/l
1.62
62
589
62
602
1.10
0.10
30.6
19.0
4.39
4.51
e12/l
0.93
62
581
62
602
1.10
0.10
30.5
19.2
7.01
6.68
e9/l
0.58
62
581
6
72
0.82
0.08
1.5
1.9
87.50
60.99
ug/g
—
6
55
16
147
1.11
0.08
3.9
3.2
—
—
—
0
0
22
234
0.92
0.07
7.5
9.7
0.00
0.00
e9/l
-0.00
17
193
50
514
0.94
0.06
3.2
3.9
1.57
1.29
mmol/l
0.86
42
472
58
568
1.06
0.05
21.7
12.5
—
—
—
0
0
14
131
1.08
0.04
10.4
6.1
—
—
—
0
0
11
113
0.97
0.00
1.5
2.0
—
—
—
0
0
37
373
0.99
0.00
3.3
3.7
—
—
—
0
0
52
515
1.02
0.00
3.9
4.3
6.98
5.98
mmol/l
0.48
46
466
15
151
0.99
0.00
4.6
3.5
9.06
15.10
mg/mmol
—
9
98
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
278.14
—
0
7
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
64.20
—
0
5
0
8
0.00
-0.00
0.0
3.0
—
—
—
0
0
6
61
0.98
-0.00
1.3
1.4
—
701.82
—
0
11
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
9.9
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.2
—
32.00
—
0
5
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
57
0.87
-0.00
1.6
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
7
76
0.91
-0.00
1.9
1.2
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ST19_SEQUEL_INJURI_INVOLVI_MULTIPLE_UNSPE_BODY_REGIONS – Sequelae of injuries involving multiple and unspecified body regions

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).